Why use it

Provides rapid, objective risk stratification at the time of ED presentation for AECOPD, before laboratory results are fully available. BAP-65 class directly guides disposition decisions (ward vs. step-down vs. ICU) and predicts the need for mechanical ventilation, which independently predicts ICU admission and ICU resource utilization.

About

The BAP-65 score is a validated clinical prediction tool for estimating in-hospital mortality and the need for mechanical ventilation in patients admitted with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Using four readily available variables — elevated BUN (B), altered mental status (A), Pulse > 109 bpm (P), and age ≥ 65 years (65) — it classifies patients into five risk classes (I through V) with escalating mortality risk. The score was derived from a large administrative database study of over 34,000 AECOPD hospitalizations.

When to use

Patients presenting to the ED or admitted with acute exacerbation of COPD
Determining appropriate level of care (general ward, step-down, ICU)
Estimating need for mechanical ventilation
Communicating prognosis and risk with patients and families
Triage in resource-limited settings

Formula

BAP-65 Components (1 point each unless otherwise noted): B = BUN > 25 mg/dL: +1 A = Altered mental status (acute confusion, disorientation): +1 P = Pulse rate > 109 bpm: +1 65 = Age ≥ 65 years: used for class assignment only Risk Classes: Class I: Age < 65 AND no B, A, or P criteria → ~0.3% mortality Class II: Age ≥ 65 AND no B, A, or P criteria → ~0.4% mortality OR Age < 65 AND exactly 1 of B, A, or P Class III: Any age with exactly 2 of B, A, P criteria → ~4.4% mortality Class IV: Any age with all 3 of B, A, P criteria → ~10.6% mortality Class V: All 3 criteria + age ≥ 65 (applies if needed for re-classification)

Pearls & pitfalls

BUN > 25 mg/dL reflects systemic illness, poor oral intake, or pre-renal state — a powerful predictor of AECOPD severity.
Altered mental status in AECOPD suggests CO₂ narcosis, severe hypoxemia, or sepsis — requires immediate ABG and consideration of NIV.
Tachycardia (HR > 109 bpm) in COPD exacerbation may reflect pain, anxiety, hypoxia, or pulmonary hypertension — investigate and treat the cause.
Class II differs from Class I only in age ≥ 65 — the slightly higher mortality in Class II reflects age-related comorbidity burden.
BAP-65 does not replace clinical judgment — always consider ABG results, spirometry, CXR, and hemodynamic status.
NIV (CPAP/BiPAP) reduces mortality and mechanical ventilation need in AECOPD with respiratory acidosis — consider early in Classes III–V.
Heliox, magnesium, and IV methylxanthines are not routinely recommended — focus on bronchodilators, steroids, antibiotics, and NIV.

Next steps

Class I (<65y, no criteria): Very low risk (~0.3% mortality) — general ward admission. Class II (≥65y or 1 criterion, not both): Low risk (~0.4%) — general ward with monitoring. Class III (1–2 criteria): Moderate risk (~4%) — step-down unit or monitored bed; prepare for possible escalation. Class IV (3 criteria): High risk (~10.6%) — step-down or ICU depending on clinical status; early mechanical ventilation if deteriorating. Class V (4 criteria): Very high risk (~11.6%) — ICU admission; anticipate need for mechanical ventilation.

Evidence

Tabak YP et al. (Chest 2009) derived BAP-65 from 34,669 COPD hospitalizations. In-hospital mortality ranged from 0.3% (Class I) to 11.6% (Class V). Mechanical ventilation rates: 0.3% (Class I) to 19.7% (Class V). Validated externally in multiple cohorts. AUC ~0.78 for in-hospital mortality. Endorsed by multiple COPD management guidelines as a simple bedside risk tool.

References

Tabak YP et al. Predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease: a risk-stratification tool. Arch Intern Med. 2009;169(9):879-886. — link
Shorr AF et al. Readmission following hospitalization for chronic obstructive pulmonary disease. Chest. 2010;137(6):1395-1401. — link

BAP-65 Score for Acute Exacerbation of COPD

Calculator